Silandrone
Introduction '''Silandrone''' (, ) (developmental code name '''SC-16148'''), also known as '''testosterone 17β-trimethylsilyl ether''' or '''17β-trimethylsilyltestosterone''', as well as '''17β-(trimethylsiloxy)androst-4-en-3-one''', is a synthetic anabolic-androgenic steroid (AAS) and an androgen ether – specifically, the 17β-trimethylsilyl ether of testosterone – which was developed by the G. D. Searle & Company in the 1960s but was never marketed. It has a very long duration of action when given via subcutaneous or intramuscular injection, as well as significantly greater potency than that of testosterone propionate. In addition, silandrone, unlike testosterone and most esters of testosterone like testosterone propionate, is orally active.
See also * List of androgen esters
References